These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31183806)

  • 21. Characterization of MCH-mediated obesity in mice.
    Ito M; Gomori A; Ishihara A; Oda Z; Mashiko S; Matsushita H; Yumoto M; Ito M; Sano H; Tokita S; Moriya M; Iwaasa H; Kanatani A
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E940-5. PubMed ID: 12554598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanin-concentrating hormone, melanocortin receptors and regulation of luteinizing hormone release.
    Murray JF; Adan RA; Walker R; Baker BI; Thody AJ; Nijenhuis WA; Yukitake J; Wilson CA
    J Neuroendocrinol; 2000 Mar; 12(3):217-23. PubMed ID: 10718917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebroventricular administration of melanin-concentrating hormone suppresses pulsatile luteinizing hormone release in the female rat.
    Tsukamura H; Thompson RC; Tsukahara S; Ohkura S; Maekawa F; Moriyama R; Niwa Y; Foster DL; Maeda K
    J Neuroendocrinol; 2000 Jun; 12(6):529-34. PubMed ID: 10844581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breviscapine exerts neuroprotective effects through multiple mechanisms in APP/PS1 transgenic mice.
    Li Z; Zhang XB; Gu JH; Zeng YQ; Li JT
    Mol Cell Biochem; 2020 May; 468(1-2):1-11. PubMed ID: 32144518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice.
    Bollen E; Vanmierlo T; Akkerman S; Wouters C; Steinbusch HM; Prickaerts J
    Behav Brain Res; 2013 Nov; 257():8-12. PubMed ID: 24070857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.
    Tan L; Yang H; Pang W; Li H; Liu W; Sun S; Song N; Zhang W; Jiang Y
    J Alzheimers Dis; 2017; 56(2):629-640. PubMed ID: 28035919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of adenosine A
    Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
    Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
    Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats.
    Della-Zuana O; Presse F; Ortola C; Duhault J; Nahon JL; Levens N
    Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1289-95. PubMed ID: 12355323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic MCH infusion causes a decrease in energy expenditure and body temperature, and an increase in serum IGF-1 levels in mice.
    Glick M; Segal-Lieberman G; Cohen R; Kronfeld-Schor N
    Endocrine; 2009 Dec; 36(3):479-85. PubMed ID: 19859841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders.
    Chung S; Verheij MM; Hesseling P; van Vugt RW; Buell M; Belluzzi JD; Geyer MA; Martens GJ; Civelli O
    PLoS One; 2011; 6(7):e19286. PubMed ID: 21818251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
    J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Lee CC; Chang CP; Lin CJ; Lai HL; Kao YH; Cheng SJ; Chen HM; Liao YP; Faivre E; Buée L; Blum D; Fang JM; Chern Y
    Mol Neurobiol; 2018 Dec; 55(12):8936-8952. PubMed ID: 29616397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. REM sleep-active MCH neurons are involved in forgetting hippocampus-dependent memories.
    Izawa S; Chowdhury S; Miyazaki T; Mukai Y; Ono D; Inoue R; Ohmura Y; Mizoguchi H; Kimura K; Yoshioka M; Terao A; Kilduff TS; Yamanaka A
    Science; 2019 Sep; 365(6459):1308-1313. PubMed ID: 31604241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
    Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
    Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.